MNK Stock Price, Chart, Stats & News

Mallinckrodt plc
Save
4.52M
Market cap
–
Current P/E
–
Forward P/E
MNK chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 41.23% |
Operating margin | -8.29% |
Pretax margin | 12.31% |
Net margin | 8.64% |
Effective tax rate | 30.32% |
ROA | 2.60% |
ROE | 10.92% |
D/E | 1.18x |
Interest coverage ratio | -0.89x |
MNK valuation
P/E | – |
P/S | 0.00x |
P/B | 0.00x |
P/CF | 0.08x |
P/FCF | -0.73x |
P/OCF | 0.08x |
PEG | -0.00x |
EV multiple | -3.60x |
About
Mallinckrodt plc operates as a global pharmaceutical company, engaged in the development, manufacturing, marketing, and distribution of specialized medical products and therapies. Its extensive reach covers the United States, Europe, the Middle East, Africa, and various other international markets. The firm's business operations are segmented into two core divisions: Specialty Brands and Specialty Generics.
Similar securities
Based on sector and market capitalization
Report issue










